34 research outputs found
The Use of Bovine Pericardial Buttress on Linear Stapler Fails to Reduce Pancreatic Fistula Incidence in a Porcine Pancreatic Transection Model
We investigate the effectiveness of buttressing the surgical stapler to reduce postoperative pancreatic fistulae in a porcine model. As a pilot study, pigs (n = 6) underwent laparoscopic distal pancreatectomy using a standard stapler. Daily drain output and lipase were measured postoperative day 5 and 14. In a second study, pancreatic transection was performed to occlude the proximal and distal duct at the pancreatic neck using a standard stapler (n = 6), or stapler with bovine pericardial strip buttress (n = 6). Results. In pilot study, 3/6 animals had drain lipase greater than 3x serum on day 14. In the second series, drain volumes were not significantly different between buttressed and control groups on day 5 (55.3 ± 31.6 and 29.3 ± 14.2 cc, resp.), nor on day 14 (9.5 ± 4.2 cc and 2.5 ± 0.8 cc, resp., P = 0.13). Drain lipase was not statistically significant on day 5 (3,166 ± 1,433 and 6,063 ± 1,872 U/L, resp., P = 0.25) or day 14 (924 ± 541 and 360 ± 250 U/L). By definition, 3/6 developed pancreatic fistula; only one (control) demonstrating a contained collection arising from the staple line. Conclusion. Buttressed stapler failed to protect against pancreatic fistula in this rigorous surgical model
Adaptive Honeypot Engagement through Reinforcement Learning of Semi-Markov Decision Processes
A honeynet is a promising active cyber defense mechanism. It reveals the
fundamental Indicators of Compromise (IoCs) by luring attackers to conduct
adversarial behaviors in a controlled and monitored environment. The active
interaction at the honeynet brings a high reward but also introduces high
implementation costs and risks of adversarial honeynet exploitation. In this
work, we apply infinite-horizon Semi-Markov Decision Process (SMDP) to
characterize a stochastic transition and sojourn time of attackers in the
honeynet and quantify the reward-risk trade-off. In particular, we design
adaptive long-term engagement policies shown to be risk-averse, cost-effective,
and time-efficient. Numerical results have demonstrated that our adaptive
engagement policies can quickly attract attackers to the target honeypot and
engage them for a sufficiently long period to obtain worthy threat information.
Meanwhile, the penetration probability is kept at a low level. The results show
that the expected utility is robust against attackers of a large range of
persistence and intelligence. Finally, we apply reinforcement learning to the
SMDP to solve the curse of modeling. Under a prudent choice of the learning
rate and exploration policy, we achieve a quick and robust convergence of the
optimal policy and value.Comment: The presentation can be found at https://youtu.be/GPKT3uJtXqk. arXiv
admin note: text overlap with arXiv:1907.0139
Strategic Learning for Active, Adaptive, and Autonomous Cyber Defense
The increasing instances of advanced attacks call for a new defense paradigm
that is active, autonomous, and adaptive, named as the \texttt{`3A'} defense
paradigm. This chapter introduces three defense schemes that actively interact
with attackers to increase the attack cost and gather threat information, i.e.,
defensive deception for detection and counter-deception, feedback-driven Moving
Target Defense (MTD), and adaptive honeypot engagement. Due to the cyber
deception, external noise, and the absent knowledge of the other players'
behaviors and goals, these schemes possess three progressive levels of
information restrictions, i.e., from the parameter uncertainty, the payoff
uncertainty, to the environmental uncertainty. To estimate the unknown and
reduce uncertainty, we adopt three different strategic learning schemes that
fit the associated information restrictions. All three learning schemes share
the same feedback structure of sensation, estimation, and actions so that the
most rewarding policies get reinforced and converge to the optimal ones in
autonomous and adaptive fashions. This work aims to shed lights on proactive
defense strategies, lay a solid foundation for strategic learning under
incomplete information, and quantify the tradeoff between the security and
costs.Comment: arXiv admin note: text overlap with arXiv:1906.1218
Ferroptosis-inducing agents compromise in vitro human islet viability and function
Human islet transplantation has been hampered by donor cell death associated with the islet preparation procedure before transplantation. Regulated necrosis pathways are biochemically and morphologically distinct from apoptosis. Recently, ferroptosis was identified as a non-apoptotic form of iron-dependent regulated necrosis implicated in various pathological conditions. Mediators of islet oxidative stress, including glutathione peroxidase-4 (GPX4), have been identified as inhibitors of ferroptosis, and mechanisms that affect GPX4 function can impact islet function and viability. Ferroptosis has not been investigated directly in human islets, and its relevance in islet transplantation remains unknown. Herein, we sought to determine whether in vitro human islet viability and function is compromised in the presence of two distinct ferroptosis-inducing agents (FIA), erastin or RSL3, and whether these effects could be rescued with ferroptosis inhibitors, ferrostatin-1 (Fer-1), or desferrioxamine (DFO). Viability, as assessed by lactate dehydrogenase (LDH) release, revealed significant death in erastin- and RSL3-treated islets, 20.3% ± 3.8 and 24.4% ± 2.5, 24 h post culture, respectively. These effects were ameliorated in islets pre-treated with Fer-1 or the iron chelator, desferrioxamine (DFO). Stimulation index, a marker of islet function revealed a significant reduction in function in erastin-treated islets (control 1.97 ± 0.13 vs. 50 μM erastin 1.32 ± 0.1) (p < 0.05). Fer-1 and DFO pre-treatment alone did not augment islet viability or function. Pre-treatment of islets with erastin or Fer-1 did not impact in vivo engraftment in an immunodeficient mouse transplant model. Our data reveal that islets are indeed susceptible to ferroptosis in vitro, and induction of this novel cell death modality leads to compromised islet function, which can be recoverable in the presence of the ferroptosis inhibitors. The in vivo impact of this pathway in islet transplantation remains elusive given the constraints of our study, but warrants continued investigation
Transplantation of Human Pancreatic Endoderm Cells Reverses Diabetes Post Transplantation in a Prevascularized Subcutaneous Site
Beta-cell replacement therapy is an effective means to restore glucose homeostasis in select humans with autoimmune diabetes. The scarcity of “healthy” human donor pancreata restricts the broader application of this effective curative therapy. “β-Like” cells derived from human embryonic stem cells (hESC), with the capacity to secrete insulin in a glucose-regulated manner, have been developed in vitro, with limitless capacity for expansion. Here we report long-term diabetes correction in mice transplanted with hESC-derived pancreatic endoderm cells (PECs) in a prevascularized subcutaneous site. This advancement mitigates chronic foreign-body response, utilizes a device- and growth factor-free approach, facilitates in vivo differentiation of PECs into glucose-responsive insulin-producing cells, and reliably restores glycemic control. Basal and stimulated human C-peptide secretion was detected throughout the study, which was abolished upon graft removal. Recipient mice demonstrated physiological clearance of glucose in response to metabolic challenge and safely retrieved grafts contained viable glucose regulatory cells
Recommended from our members
Human Islet Viability and Function Is Maintained During High-density Shipment in Silicone Rubber Membrane Vessels
BackgroundThe shipment of human islets (IE) from processing centers to distant laboratories is beneficial for both research and clinical applications. The maintenance of islet viability and function in transit is critically important. Gas-permeable silicone rubber membrane (SRM) vessels reduce the risk of hypoxia-induced death or dysfunction during high-density islet culture or shipment. SRM vessels may offer additional advantages: they are cost-effective (fewer flasks, less labor needed), safer (lower contamination risk), and simpler (culture vessel can also be used for shipment).MethodIE were isolated from two manufacturing centers and shipped in 10-cm(2) surface area SRM vessels in temperature- and pressure-controlled containers to a distant center after at least 2 days of culture (n = 6). Three conditions were examined: low density (LD), high density (HD), and a microcentrifuge tube negative control (NC). LD was designed to mimic the standard culture density for IE preparations (200 IE/cm(2)), while HD was designed to have a 20-fold higher tissue density, which would enable the culture of an entire human isolation in 1-3 vessels. Upon receipt, islets were assessed for viability (measured by oxygen consumption rate normalized to DNA content [OCR/DNA)]), quantity (measured by DNA), and, when possible, potency and function (measured by dynamic glucose-stimulated insulin secretion measurements and transplants in immunodeficient B6 Rag(+/-) mice). Postshipment OCR/DNA was not reduced in HD vs LD and was substantially reduced in the NC condition. HD islets exhibited normal function postshipment. Based on the data, we conclude that entire islet isolations (up to 400,000 IE) may be shipped using a single, larger SRM vessel with no negative effect on viability and ex vivo and in vivo function